For a piece in this week’s issue, Siddhartha Mukherjee, a physician who writes about medicine and science for The New Yorker, ...

A urine-based cancer risk screening kit developed by a Japanese startup is showing promise in detecting cancer at the earliest stage using non-invasive means. The test kit from Craif Inc., a spin-off ...

The 'miSignal' test kit is able to assess the risk of up to seven cancer types using only a small urine sample.

A breakthrough in AI breast cancer detection technology has been approved by the FDA. The tech company, “Clairity,” is responsible for the first FDA-approved AI platform that helps predict a ...

The DOH reports that cervical cancer is now the second most common cancer in women, after breast cancer. About 7,800 Filipinos are diagnosed yearly. Garcia confirmed that cervical cancer cases are ...

A win for patients and pulmonologists alike, a major advancement in lung cancer detection has arrived at both of Topeka’s major hospitals–robotic-assisted bronchoscopy technology.

Researchers from Geneseeq and a network of Chinese academic hospitals have validated a blood test that can detect a broad range of cancers with high accuracy using cell-free DNA. A multi-cancer ...

Before they become invasive, at stages known as dysplasia and carcinoma in situ, early cancer cells alter the epithelial-cell architecture. In particular, the nuclei become enlarged, crowded and ...

TUESDAY, June 10, 2025 (HealthDay News) — Blood tests can detect evidence of cancer three years earlier than the disease would otherwise be diagnosed, a new small-scale pilot study says.

BOULDER, Colo. - Foresight Diagnostics, known for its advancements in minimal residual disease (MRD) detection, unveiled a strategic partnership with QIAGEN (NYSE: QGEN) on Monday.

CA-125 This blood test may be recommended to detect ovarian cancer in women who are at high risk. It’s often used along with a transvaginal ultrasound. Skin Exam With a skin exam, ...